The tumor promoting effect of BMP4 is potentially mediated by SMAD4-independent non-canonical signalling that leads to accelerated DNA replication and cell cycle progression, which needs to be considered if patients with SMAD4-low/null tumors were to receive therapies that activate BMP signalling. The gene discussed is SMAD4; the disease is neoplasm.